![A171: Tocilizumab Dosing in Juvenile Idiopathic Arthritis: Optimizing for Different Juvenile Idiopathic Arthritis Type and Patient Body Weight]()
A171: Tocilizumab Dosing in Juvenile Idiopathic Arthritis: Optimizing for Different Juvenile Idiopathic Arthritis Type and Patient Body WeightLu, Peng; Hsu, Joy; Keane, Caroline; Fettner, Scott; Wang, Jianmei; Ruperto, Nicolino; Harari, Olivier; Brunner, Hermine; Benedetti, Fabrizio De · Arthritis & Rheumatology · 2014